• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性切除术后躯干和肢体软组织肉瘤的术后并发症的肿瘤学影响。

The Oncologic Impact of Postoperative Complications Following Resection of Truncal and Extremity Soft Tissue Sarcomas.

机构信息

Division of Surgical Oncology, Department of Surgery, Emory Winship Cancer Institute, Emory University, Atlanta, GA, USA.

Department of Orthopedic Surgery, Emory University, Atlanta, GA, USA.

出版信息

Ann Surg Oncol. 2017 Nov;24(12):3574-3586. doi: 10.1245/s10434-017-6034-9. Epub 2017 Sep 11.

DOI:10.1245/s10434-017-6034-9
PMID:28895084
Abstract

INTRODUCTION

Postoperative complications (POCs) negatively impact oncologic outcomes in some malignancies; however, little is known regarding their effect in soft tissue sarcoma (STS). The aim of this study was to determine the impact of POCs on survival after resection of truncal and extremity STS.

METHODS

All patients who underwent resection for a primary truncal or extremity STS at a single academic institution from 2000 to 2015 were included and analyzed. Primary outcome was disease-specific survival (DSS).

RESULTS

Among 546 STS patients, POCs occurred in 159 (29%) patients; 57% were major and 55% were surgical site infections. Patients with POCs were older (61 vs. 53 years), had more comorbidities (50 vs. 38%), longer operative time (127 vs. 93 min), higher-grade tumors (93 vs. 86%), and were more likely to receive preoperative radiation (42 vs. 33%; all p < 0.05). There was no difference in receipt of postoperative therapy between the POCs and no POCs groups (19 vs. 18%, p = 0.74). Median follow-up for survivors was 37 months, and the 5-year DSS for the entire cohort was 78%. Compared with patients without POCs, patients with POCs had a worse DSS (68% vs. 81%, p = 0.001). Predictors for decreased DSS on univariate analysis included POCs (hazard ratio [HR] 2.12, 95% confidence interval [CI] 1.37-3.28, p = 0.001), advanced age, neurovascular/bone resection, positive margin, high grade, and preoperative and postoperative therapy (all p < 0.05). POCs (HR 1.76, 95% CI 1.08-2.87, p = 0.02) remained an independent predictor for reduced DSS on multivariate analysis, along with age (HR 1.02, p = 0.046) and tumor grade (HR 7.62, p = 0.046).

CONCLUSIONS

POCs following resection of truncal and extremity STS are associated with decreased DSS. Efforts to optimize modifiable risk factors and decrease the rate of POCs warrant further investigation.

摘要

背景

术后并发症(POC)会对某些恶性肿瘤的肿瘤学结局产生负面影响;然而,关于其对软组织肉瘤(STS)的影响知之甚少。本研究旨在确定 POC 对单一学术机构 2000 年至 2015 年间接受原发性躯干或四肢 STS 切除术患者的生存结果的影响。

方法

本研究纳入并分析了在单一学术机构接受原发性躯干或四肢 STS 切除术的所有患者。主要结局为疾病特异性生存(DSS)。

结果

在 546 名 STS 患者中,159 名(29%)患者发生了 POC;57%为主要 POC,55%为手术部位感染。发生 POC 的患者年龄更大(61 岁比 53 岁),合并症更多(50%比 38%),手术时间更长(127 分钟比 93 分钟),肿瘤分级更高(93%比 86%),且更有可能接受术前放疗(42%比 33%;所有 P<0.05)。POC 组和无 POC 组患者术后治疗的接受率无差异(19%比 18%,P=0.74)。幸存者的中位随访时间为 37 个月,整个队列的 5 年 DSS 为 78%。与无 POC 的患者相比,发生 POC 的患者 DSS 更差(68%比 81%,P=0.001)。单因素分析中,降低 DSS 的预测因素包括 POC(风险比[HR]2.12,95%置信区间[CI]1.37-3.28,P=0.001)、高龄、神经血管/骨切除、阳性切缘、高级别和术前及术后治疗(均 P<0.05)。多因素分析中,POC(HR 1.76,95%CI 1.08-2.87,P=0.02)以及年龄(HR 1.02,P=0.046)和肿瘤分级(HR 7.62,P=0.046)仍然是降低 DSS 的独立预测因素。

结论

躯干和四肢 STS 切除术后发生 POC 与降低 DSS 相关。进一步调查优化可改变的危险因素和降低 POC 发生率的努力是值得的。

相似文献

1
The Oncologic Impact of Postoperative Complications Following Resection of Truncal and Extremity Soft Tissue Sarcomas.根治性切除术后躯干和肢体软组织肉瘤的术后并发症的肿瘤学影响。
Ann Surg Oncol. 2017 Nov;24(12):3574-3586. doi: 10.1245/s10434-017-6034-9. Epub 2017 Sep 11.
2
The Prognostic Value of Lymphovascular Invasion in Truncal and Extremity Soft Tissue Sarcomas: An Analysis from the National Cancer Database.原发于躯干和肢体软组织肉瘤中淋巴管血管侵犯的预后价值:来自国家癌症数据库的分析。
Ann Surg Oncol. 2019 Dec;26(13):4723-4729. doi: 10.1245/s10434-019-07805-x. Epub 2019 Sep 9.
3
The impact of unplanned excisions of truncal/extremity soft tissue sarcomas: A multi-institutional propensity score analysis from the US Sarcoma Collaborative.原发/肢体软组织肉瘤的计划性切除对肿瘤学结局的影响:美国肉瘤协作组的多机构倾向评分分析。
J Surg Oncol. 2019 Sep;120(3):332-339. doi: 10.1002/jso.25521. Epub 2019 Jun 6.
4
Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.部位对肢体软组织肉瘤辅助放疗治疗比的影响。
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):202-8. doi: 10.1016/j.ijrobp.2005.01.011.
5
High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma.高社区水平社会脆弱性与肢体和躯干软组织肉瘤切除后无复发生存(RFS)较差相关。
Ann Surg Oncol. 2024 Jun;31(6):4138-4147. doi: 10.1245/s10434-024-15074-6. Epub 2024 Feb 23.
6
Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.高级躯干和四肢软组织肉瘤辅助化疗的使用趋势。
J Surg Res. 2020 Jan;245:577-586. doi: 10.1016/j.jss.2019.08.002. Epub 2019 Sep 5.
7
Soft Tissue Sarcomas of the Extremities: Surgical Margins Can Be Close as Long as the Resected Tumor Has No Ink on It.四肢软组织肉瘤:只要切除的肿瘤没有墨水,手术切缘就可以很近。
Oncologist. 2017 Nov;22(11):1400-1410. doi: 10.1634/theoncologist.2016-0498. Epub 2017 Jul 24.
8
Comparison of outcome and toxicity of postoperative intensity-modulated radiation therapy with two-dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk.比较两种术后调强放疗和二维放疗在四肢和躯干软组织肉瘤患者中的疗效和毒性。
Cancer Med. 2019 Mar;8(3):902-909. doi: 10.1002/cam4.1919. Epub 2019 Feb 10.
9
Growth Rate and Outcomes in Locally Recurrent Extremity and Truncal Soft Tissue Sarcoma.局部复发性肢体和躯干软组织肉瘤的生长速度和结局。
JAMA Netw Open. 2024 Sep 3;7(9):e2431530. doi: 10.1001/jamanetworkopen.2024.31530.
10
Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.评估新辅助化疗在原发性高风险躯干/肢体软组织肉瘤中的作用:美国肉瘤协作多机构分析。
Ann Surg Oncol. 2019 Oct;26(11):3542-3549. doi: 10.1245/s10434-019-07639-7. Epub 2019 Jul 24.

引用本文的文献

1
Postoperative Complications Result in Poor Oncological Outcomes: What Is the Evidence?术后并发症导致不良的肿瘤学结局:有何证据?
Curr Oncol. 2024 Aug 15;31(8):4632-4655. doi: 10.3390/curroncol31080346.
2
Prognostic Factors Associated with Tumor Recurrence and Overall Survival in Soft Tissue Sarcomas of the Extremities in a Colombian Reference Cancer Center.与哥伦比亚参考癌症中心四肢软组织肉瘤肿瘤复发和总生存相关的预后因素。
Curr Oncol. 2024 Mar 26;31(4):1725-1738. doi: 10.3390/curroncol31040131.
3
Risk Factors for Occurrence and Relapse of Soft Tissue Sarcoma.
软组织肉瘤发生和复发的危险因素
Cancers (Basel). 2022 Mar 1;14(5):1273. doi: 10.3390/cancers14051273.
4
Thirty-Day Outcomes after Surgery for Primary Sarcomas of the Extremities: An Analysis of the NSQIP Database.肢体原发性肉瘤手术后的30天预后:国家外科质量改进计划(NSQIP)数据库分析
J Oncol. 2020 Jan 13;2020:7282846. doi: 10.1155/2020/7282846. eCollection 2020.
5
Negative Impact of Wound Complications on Oncologic Outcome of Soft Tissue Sarcomas of the Chest Wall.伤口并发症对胸壁软组织肉瘤肿瘤学结局的负面影响。
Cancers (Basel). 2019 Dec 31;12(1):101. doi: 10.3390/cancers12010101.
6
CORR Insights®: Is a Nomogram Able to Predict Postoperative Wound Complications in Localized Soft-tissue Sarcomas of the Extremity?CORR见解®:列线图能否预测肢体局限性软组织肉瘤的术后伤口并发症?
Clin Orthop Relat Res. 2020 Mar;478(3):560-562. doi: 10.1097/CORR.0000000000001011.